Нейроэндокринные механизмы регуляции пищевого поведения (обзор)

Автор: Болотова Н.В., Курдиян М.С., Филина Н.Ю.

Журнал: Саратовский научно-медицинский журнал @ssmj

Статья в выпуске: 3 т.16, 2020 года.

Бесплатный доступ

В обзоре анализируются опубликованные данные о роли различных нейротрансмиттеров, гормонов, участвующих в формировании и нарушении пищевого поведения. Для поиска статей использовалась база PubMed, а также архивы журналов «ПедиатрЪ», «Медицина: теория и практика «Окружающая среда и энерговедение», «Проблемы эндокринологии», «Современные технологии в медицине», «Российский кардиологический журнал», «Universum: медицина и фармакология», «Вопросы детской диетологии», Курского научно-практического вестника «Человек и его здоровье». В обзоре литературы использовано 49 источников литературы, статьи опубликованы в период с 2004 по 2020 г.

Еще

Гормоны, нейротрансмиттеры, ожирение, пищевое поведение

Короткий адрес: https://sciup.org/149135587

IDR: 149135587

Список литературы Нейроэндокринные механизмы регуляции пищевого поведения (обзор)

Baranov AA. Preventive Pediatrics: A Guide for Physicians. M.: Pediatric, 2015; 744 p. Russian (Баранов А. А. Профилактическая педиатрия: руководство для врачей. М.: ПедиатрЪ, 2015; 744 с.).
Van Galen KA, Ter Horst KW, Booij J, et al. The role of central dopamine and serotonin in human obesity: lessons learned from molecular neuroimaging studies. Metabolism 2018; (85): 325-39.
Naef L, Pitman KA, Borgland SL. Mesolimbic dopamine and its neuromodulators in obesity and binge eating. CNS Spectr 2015; 20 (6): 574-83.
Kumar M, Chail M. Sucrose and saccharin differentially modulate depression and anxiety-like behavior in diabetic mice: exposures and withdrawal effects. Psychopharmacology (Berl) 2019; 236 (11): 3095-110.
McCuen-Wurst C, Ruggieri M, Allison KC. Disordered eating and obesity: associations between binge-eating disorder, night-eating syndrome, and weight-related comorbidities. Ann N Y Acad Sci 2018; 1411 (1): 96-105.
Park HJ, Lee SE, Kim HB, et al. Association of obesity with serum leptin, adiponectin, and serotonin and gut microflora in beagle dogs. J Vet Intern Med 2015; 29 (1): 43-50.
Ojeda-Rodríguez A, Morell-Azanza L, Azcona-Sanjulián MC, et al. Reduced serotonin levels after a lifestyle intervention in obese children: association with glucose and anthropometric measurements. Disminución de los niveles de serotoninatrasunaintervención de estilo de vidaenniñosobesos: asociación con glucosa y medidasantropométricas. Nutr Hosp 2018; 35 (2): 279-85.
Johnson PM, Kenny PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci 2010; 13 (5): 635-41.
Beeler JA, Faust rP, Turkson S, et al. Low Dopamine D2 Receptor Increases Vulnerability to Obesity Via Reduced Physical Activity, Not Increased Appetitive Motivation. Biol Psychiatry 2016; 79 (11): 887-97.
Crane JD, Palanivel R, Mottillo EP, et al. Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis. Nat Med 2015; 21 (2): 166-72.
Watanabe H, Nakano T, Saito R, et al. Serotonin Improves High Fat Diet Induced Obesity in Mice. PLoS One. URL: https://doi.org/10.1371/journal. pone. 0147143 (14 Jan 2016).
Ailanen L, Ruohonen ST, Vähätalo LH, et al. The metabolic syndrome in mice overexpressing neuropeptide Y in noradrenergic neurons. J Endocrinol 2017; 234 (1): 57-72.
Kim YJ, Bi S. Knockdown of neuropeptide Y in the dorsomedial hypothalamus reverses high-fat diet-induced obesity and impaired glucose tolerance in rats. Am J Physiol Regul Integr Comp Physiol 2016; 310 (2): 134-42.
Listopadova AP, Petrenko YuV. Neuropeptide Y: physiological role and clinical significance. Medicine: theory and practice 2018; (3): 157-62. Russian (Листопадова А. П., Петренко Ю. В. Нейропептид Y: физиологическая роль и клиническое значение. Медицина: теория и практика 2018; (3): 157-62).
Dodonova SA, Belykh AE, Bobyntsev II. Regulatory Peptides of the Melanocortin Family: Biosynthesis, Reception, Biological Effects. Kursk scientific and practical bulletin "Man and his health" 2018; (1): 99-108. Russian (Додонова С. А., Белых А. Е., Бобынцев И. И. Регуляторные пептиды семейства меланокортинов: биосинтез, рецепция, биологические эффекты. Курский научно-практический вестник «Человек и его здоровье» 2018; (1): 99-108).
Osipova АА. The role of leptin in the regulation of energy metabolism and the functioning of living organisms. Environment and Energy 2019; (2): 55-82. Russian (Осипова А. А. Роль леп-тина в регуляции энергетического обмена и функционировании организмов живой природы. Окружающая среда и энерговедение 2019; (2): 55-82).
Vehapoglu A, Türkmen S, Terzioglu §. Alpha-Melanocyte-Stimulating Hormone and Agouti-Related Protein: Do They Play a Role in Appetite Regulation in Childhood Obesity? J Clin Res Pediatr Endocrinol 2016; 8 (1): 40-7.
Roseberry AG, Stuhrman K, Dunigan AI. Regulation of the mesocorticolimbic and mesostriatal dopamine systems by a-melanocyte stimulating hormone and agouti-related protein. Neurosci Biobehav Rev 2015; (56): 15-25.
Ikeda H, Ardianto C, Yonemochi N, et al. Inhibition of opioid systems in the hypothalamus as well as the mesolimbic area suppresses feeding behavior of mice. Neuroscience 2015; (311): 9-21.
Valbrun LP, Zvonarev V. The Opioid System and Food Intake: Use of Opiate Antagonists in Treatment of Binge Eating Disorder and Abnormal Eating Behavior. J Clin Med Res. 2020; 12 (2): 41-63.
Gmoshinskiy IV, Apryatin SA, Shipelin VA, et al. Neuromediators and neuropeptides: the biomarkers for metabolic disturbances in obesity. Problems of Endocrinology 2018; 64 (4): 258-69. Russian (Гмошинский И. В., Апрятин С. А., Шипе-лин В. А. и др. Нейромедиаторы и нейропептиды — биомаркеры метаболических нарушений при ожирении. Проблемы эндокринологии 2018; 64 (4): 258-69).
Gruden G, Barutta F, Kunos G, et al. Role of the endocannabinoid system in diabetes and diabetic complications. Br J Pharmacol 2016; 173 (7): 1116-27.
Zink AN, Bunney PE, Holm AA, et al. Neuromodulation of orexin neurons reduces diet-induced adiposity. Int J Obes (Lond) 2018; 42 (4): 737-45.
Gilon P. Cocaine- and amphetamine-regulated transcript: a novel regulator of energy homeostasis expressed in a subpopulation of pancreatic islet cells. Diabetologia 2016; 59 (9): 1855-9.
Muñoz-Rodríguez JR, Agarrado A, Martín-Fernández J, et al. Cocaine and amphetamine regulated transcript and brain-derived neurotrophic factor in morbid obesity. One-year follow-up after gastric bypass. Surg Obes Relat Dis 2018; 14 (11): 1732-9.
Aloe L, Rocco ML, Bianchi P, et al. Nerve growth factor: from the early discoveries to the potential clinical use. J Transl Med 2012; (10): 239-52.
Sun Q, Tang DD, Yin EG, et al. Diagnostic Significance of Serum Levels of Nerve Growth Factor and Brain Derived Neurotrophic Factor in Diabetic Peripheral Neuropathy. Med Sci Monit 2018; (24): 5943-50.
Mantelli F, Lambiase A, Colafrancesco V, et al. NGF and VEGF effects on retinal ganglion cell fate: new evidence from an animal model of diabetes. Eur J Ophthalmol 2014; 24 (2): 24753.
Lotosh NG, Savel'eva EK, Selishcheva AA, et al. Autoantibodies to neuron-specific proteins S100, GFAP, MBP and NGF in the serum of rats with streptozotocin- induced diabetes. Bull Exp Biol Med 2013; 155 (1): 48-51.
Hou Y, Linpei J, Zhang Y, et al. Activation of the NGF/TrkA signaling pathway attenuates diabetic erectile dysfunction. Oncotarget 2017; 8 (62): 105692-702.
Uenoyama Y, Inoue N, Nakamura S, et al. Central mechanism controlling pubertal onset in mammals: A triggering role of kisspeptin. Front. Endocrinol. (Lausanne) 2019; (10): 312.
Quennell JH, Howell CS, Roa J, et al. Leptin deficiency and diet-induced obesity reduce hypothalamic kisspeptin expression in mice. Endocrinology 2011; 152 (4): 1541-50.
Song W-J, Mondal P, Wolfe A, et al. Glucagon regulates hepatic kisspeptin to impair insulin secretion. Cell Metab 2014; 19 (4): 667-81.
Zagoskin PP, Zagoskina IP, Savel'eva NA, et al. Modern Approaches to the Problem of Body Weight Regulation. Modern technologies in medicine 2014; 6 (3): 104-17. Russian (Загоскин П. П., Загоскина И. П., Савельева Н. А. и др. Современные подходы к проблеме регуляции массы тела (обзор). Современные технологии в медицине 2014; 6 (3): 104-17).
Acar S, Paketpi A, Kume T, et al. Positive correlation of galanin with insulin resistance and triglyceride levels in obese children. Turk J Med Sci 2018; 48 (3): 560-8.
Duan DM, Jhang JY, Wu S, et al. Modification effect of sex and obesity on the correlation of LEP polymorphisms with leptin levels in Taiwanese obese women. Mol Genet Genomic Med. URL: https://doi.org/10.1002/mgg3.1113 (8 Jan 2020).
Baldini G, Phelan KD. The melanocortin pathway and control of appetite-progress and therapeutic implications. J Endocrinol 2019; 241 (1): 1-33.
Chumakova GA, Ott AV, Veselovskaya NG, et al. Pathogenetic mechanisms of leptin resistance. Russian Journal of Cardiology 2015; 4 (120):107-10. Russian (Чумакова Г. А., Отт А. В., Веселовская Н. Г. и др. Патогенетические механизмы лептинорезистентности. Российский кардиологический журнал 2015; 4 (120): 107-10).
Lv Y, Liang T, Wang G, et al. Ghrelin, a gastrointestinal hormone, regulates energy balance and lipid metabolism. Biosci Rep. URL: http://dx.doi.org/10.1042/BSR20181061 (25 Sep 2018).
Nesic DM, Stevanovic DM, Stankovic SD, et al. Age-dependent modulation of central ghrelin effects on food intake and lipid metabolism in rats. Eur J Pharmacol 2013; (710): 85-91.
Achari AE, Jain SK. Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction. Int J Mol Sci 2017; 18 (6): 1321.
Al-Hamodi Z, Al-Habori M, Al-Meeri A, et al. Assosiation of adipokines, leptin/adiponectin ratio and C-reactive protein with obesity and tipe 2 diabetes mellitus. Diabet Metabol Syndrome 2014; 6 (1): 99.
Parfenova NS, Tanyansky DA. Adiponectin: effects on metabolic and cardiovascular disorders. Arterial Hypertension 2013, 19 (1): 84-96.
Finan B' et al. Reappraisal of GIP Pharmacology for Metabolic Diseases. Trends Mol Med 2016; (22): 359-76.
Gupta P, Bala M, Gupta S, et al. Efficacy and risk profile of anti-diabetic therapies: Conventional vs traditional drugs-A mechanistic revisit to understand their mode of action. Pharmacol Res 2016; (113): 636-74.
Volkov VP. New pancreatic hormones: amylin (literature review). Universum: medicine and pharmacology, 2014; 11 (12): 1. Russian (Волков В. П. Новые панкреатические гормоны: амилин (обзор литературы). Universum: медицина и фармакология 2014; 11 (12): 1).
Bolotova NV, Raigorodskaya NYu, Averyanov AP, et al. Specificities of neuroendocrine-immune status in obese adolescent boys. Vopr. det. dietol. (Pediatric Nutrition). 2020; 18 (2): 15-22. Russian (Болотова Н. В, Райгородская Н. Ю., Аверьянов А. П. и др. Особенности нейроэндокринно-иммунного статуса мальчиков-подростков с ожирением. Вопросы детской диетологии 2020; 18 (2): 15-22).
Yanik T, Dominguez G, Kuhar MJ, et al. The Leu34Phe ProCART mutation leads to cocaine- and amphetamine-regulated transcript (CART) deficiency: a possible cause for obesity in humans. Endocrinology 2006; 147 (1): 39-43.
Rubino F, Gagner M, Gentileschi P, et al. The early effect of Roux-en-Y gastric bypass on hormones is involved in body weight regulation and glucose metabolism. AnnSurg 2004; (240): 236-42.

Еще

Статья научная